American Society of Hematology--50th Annual Meeting and Exposition--Part 2.
Cleverley
John
J
Thomson Reuters, 77 Hatton Garden, London EC1N8JS, UK. john.cleverley@thomsonreuters.com
Millar
Enda
E
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002648:Child; D002986:Clinical Trials as Topic; D016326:Extracellular Matrix Proteins / Q000276:immunology; D006801:Humans; D018960:Hyaluronan Receptors / Q000276:immunology; D007938:Leukemia / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008213:Lymphocyte Activation / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy* / Q000503:physiopathology; D012958:Societies, Scientific; D014481:United States
D000970:Antineoplastic Agents; D016326:Extracellular Matrix Proteins; D018960:Hyaluronan Receptors; C098946:hyaluronan-mediated motility receptor